ATE136021T1 - Verfahren zur herstellung von n1,n4- diethylspermin - Google Patents

Verfahren zur herstellung von n1,n4- diethylspermin

Info

Publication number
ATE136021T1
ATE136021T1 AT92203575T AT92203575T ATE136021T1 AT E136021 T1 ATE136021 T1 AT E136021T1 AT 92203575 T AT92203575 T AT 92203575T AT 92203575 T AT92203575 T AT 92203575T AT E136021 T1 ATE136021 T1 AT E136021T1
Authority
AT
Austria
Prior art keywords
general formula
stands
chem
pharmaceutically acceptable
compound
Prior art date
Application number
AT92203575T
Other languages
English (en)
Inventor
Raymond J Bergeron Jr
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE136021T1 publication Critical patent/ATE136021T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/06Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
    • C07C209/08Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dentistry (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Hematology (AREA)
  • Environmental Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92203575T 1986-12-02 1987-12-01 Verfahren zur herstellung von n1,n4- diethylspermin ATE136021T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93683586A 1986-12-02 1986-12-02

Publications (1)

Publication Number Publication Date
ATE136021T1 true ATE136021T1 (de) 1996-04-15

Family

ID=25469139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92203575T ATE136021T1 (de) 1986-12-02 1987-12-01 Verfahren zur herstellung von n1,n4- diethylspermin

Country Status (6)

Country Link
EP (2) EP0270349B1 (de)
JP (1) JPH0653661B2 (de)
AT (1) ATE136021T1 (de)
CA (1) CA1305425C (de)
DE (2) DE3786896T2 (de)
ES (2) ES2059398T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091576A (en) * 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5753714A (en) * 1987-02-03 1998-05-19 Merrell Pharmaceuticals Inc. Polyamine derivatives
US5654484A (en) * 1987-10-08 1997-08-05 Merrell Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
ZA887410B (en) * 1987-10-08 1989-06-28 Merrell Dow Pharma Polyamine derivatives as antineoplastic agents
DE69018099T2 (de) * 1989-01-10 1995-08-03 Merrell Dow Pharma Polyamin-Derivate als antineoplastische Mittel.
US5561136A (en) * 1990-12-13 1996-10-01 Merrell Pharmaceuticals Inc. Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
GB9105489D0 (en) * 1991-03-15 1991-05-01 Johnson Matthey Plc Improvements in chemical compounds
FR2714052B1 (fr) * 1993-12-22 1996-02-02 Synthelabo Préparation de polyamines substituées sur les deux azotes terminaux.
DK0686143T3 (da) * 1993-12-27 1999-05-17 Novartis Ag Umættede aminoforbindelser som middel mod cancer og mod protozoer
ES2164875T3 (es) * 1995-03-15 2002-03-01 Novartis Ag Poliaminas lineales sustituidas con piperidinil-2-alquilo para la reduccion de niveles de poliaminas endogenas intracelulares, tales como putrescina, espermidina y espermina, y su impacto sobre la profileracion celular.
JP3891496B2 (ja) * 1996-10-18 2007-03-14 ウイスコンシン アルムニ リサーチ ファウンデイション 立体配座的に制限のあるポリアミン類
US5889061A (en) 1997-10-15 1999-03-30 Wisconsin Alumni Research Foundation Conformationally restricted polyamines
US7045550B2 (en) 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
MX2017000447A (es) * 2014-07-11 2017-04-27 Genzyme Corp Poliaminas de cadena principal.
WO2018059216A1 (zh) * 2016-09-29 2018-04-05 广州君赫生物科技有限公司 降低saicar合成酶活性的化合物及应用
US11517541B2 (en) 2017-04-20 2022-12-06 Geneheal Biotechnology Co., Ltd. Applications of spermidine and its derivatives
JP6810814B2 (ja) * 2017-04-20 2021-01-06 広州君赫生物科技有限公司 抗腫瘍薬の調製におけるスペルミン及びその誘導体の使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606348B2 (ja) * 1976-03-31 1985-02-18 三菱化学株式会社 新規ポリアミン類
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤

Also Published As

Publication number Publication date
JPS63211225A (ja) 1988-09-02
EP0536853B1 (de) 1996-03-27
JPH0653661B2 (ja) 1994-07-20
EP0270349B1 (de) 1993-08-04
CA1305425C (en) 1992-07-21
DE3786896T2 (de) 1993-12-23
DE3751764D1 (de) 1996-05-02
EP0270349A3 (en) 1990-09-12
EP0536853A3 (en) 1993-05-12
DE3786896D1 (de) 1993-09-09
DE3751764T2 (de) 1996-10-31
ES2059398T3 (es) 1994-11-16
EP0270349A2 (de) 1988-06-08
ES2088091T3 (es) 1996-08-01
EP0536853A2 (de) 1993-04-14

Similar Documents

Publication Publication Date Title
ATE136021T1 (de) Verfahren zur herstellung von n1,n4- diethylspermin
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
DE3370478D1 (en) Isoquinolinesulfonamide derivatives and process for the preparation thereof
ATE22889T1 (de) 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3762236D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
ES2076147T3 (es) Nuevos derivados de amina ciclicos, medicamento que contiene estos compuestos y procedimiento para su preparacion.
ES2029885T3 (es) Metodo para preparar acidos ariltioalquilfenil-carboxilicos.
AU8004291A (en) Use of alkyl phospholipids as antiviral drugs, as well as new compounds
DE69108014D1 (de) Verfahren zur herstellung von nucleosiden und ihre analogen.
DE3768319D1 (de) Verfahren zur herstellung von o-substituierten hydroxylaminen.
ATE477227T1 (de) Verfahren zur herstellung eines trans-4-amino-1- cyclohexancarbonsäurederivats
ATE107920T1 (de) Verfahren zur herstellung einer chinolincarbonsäure.
ATE185802T1 (de) Verfahren zur herstellung von 1-methylindazol-3- carbonsäure
HUT47398A (en) Antiparasitic compositions comprising 2,2-dimethyl-cyclopropanecarboxylic acid derivatives and process for producing the active ingredients and their intermediates
DE69809888T2 (de) Verfahren zur Herstellung von alpha-Aminoketonen
DE69604642T2 (de) Verfahren zur herstellung von iodierten kontrastmitteln
ATE21387T1 (de) Hydrochinonabkoemmlinge, sowie verfahren zu deren herstellung.
ATE23989T1 (de) Verfahren zur herstellung von n,n'-bis(2hydroxyethyl)oxamid.
ATE165824T1 (de) Verfahren zur herstellung von 2-perfluoroalkyl-3- oxazolin-5-one
DE3750117D1 (de) Verfahren zur Herstellung von Indolinon-2-Derivaten.
ATE127775T1 (de) Verfahren zur herstellung von alpha-omega- alkandicarbonsäuren.
ATE77091T1 (de) Verfahren zur herstellung von alphaaminoalkylphosphons|uren.
ATE68787T1 (de) Verfahren zur herstellung von n-acylierten mercapto-alpha-aminosaeuren.
SE7602856L (sv) Nya substituerade arylalkylaminer
DE69318546D1 (de) Verfahren zur herstellung von prostaglandin e

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee